Initial Clinical Experience with the NeVa thrombectomy device
Last update on October 22, 2021
Join Dr. Joaquín Zamarro Parra from Hospital Clínico Universitario Virgen de la Arrixaca in Spain as he discusses the encouraging initial clinical results of the Vesalio NeVa™ thrombectomy device – Do the NEVA DROP ZONES™ make a difference?
In NeVa NET™, Distal Embolic Filtration and Drop Zone™ technologies work together to enhance clot capture and retention, providing effective recanalization in ischemic stroke thrombectomy. The new...
Nashville, TN, June 2, 2021 Vesalio announces it has successfully secured a Class A financing round. The proceeds will be utilized to support the ongoing US IDE stroke study, establish US infrastru...
Nashville, TN, May 11, 2021 Vesalio announces another key milestone to support entry into the US neurovascular thrombectomy market. Enrollment has commenced in the Vesalio CLEAR(1) acute ischemic s...
Nashville, TN, April 28, 2021, Vesalio announces it has accomplished a key FDA IDE study milestone to support entry into the US neurovascular market. Enrollment in the VITAL1 clinical trial, assess...
